Skip to main content
logo
MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
2.790
+0.010 (0.36%)
Aug 3, 2026, 1:32 PM CET

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5291111818088
Market Cap Growth
-42.33%-18.48%36.95%1.97%-9.59%-
Enterprise Value
44.9683.01106.7865.1955.2650
Last Close Price
2.794.817.966.988.0013.35

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.5820.0134.5336.3955.6090.51
PB Ratio
29.1250.3210.744.133.062.24
P/TBV Ratio
--12.144.113.070.83

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.9418.3533.2029.2538.6451.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
8.318.311.240.350.350.09
Net Debt / Equity Ratio
-4.18-4.18-0.41-0.90-1.01-1.02
Net Debt / EBITDA Ratio
0.270.270.160.802.014.09
Net Debt / FCF Ratio
0.460.460.190.891.984.89
Asset Turnover
0.110.110.090.060.030.03
Inventory Turnover
18.9218.929.8305.100
Quick Ratio
1.941.941.893.851.904.55
Current Ratio
1.941.941.904.281.974.59
Return on Equity (ROE)
-511.92%-511.92%-192.28%-82.75%-42.04%-30.20%
Return on Assets (ROA)
-71.59%-71.59%-76.12%-48.37%-29.61%-22.90%
Return on Invested Capital (ROIC)
--16988.00%-696.23%-2160.00%--
Return on Capital Employed (ROCE)
-115.42%-115.42%-109.04%-91.50%-45.34%-34.22%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-21.97%-21.97%-14.95%-14.89%-307.65%-135.06%
Total Shareholder Return
-21.97%-21.97%-14.95%-14.89%-307.65%-135.06%